Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study

Abstract

TAC and IFX had similar effects on remission induction in patients with severely active UC. Sequential therapies could rescue patients with UC who failed initial treatment with TAC or IFX. In clinical practice, sequential therapies might be deliberately performed.